Translating research into patient benefits
The Imperial NIHR Biomedical Research Centre (BRC) undertakes translational research, which means taking the findings from basic research more quickly and efficiently into medical practice and, thus, improving health outcomes for our patients.
Research is undertaken across a broad range of subjects; read more in each of the themes listed below.
The NIHR BioResource for Rare Diseases is an integral part of the NIHR BioResource (nihrbioresource.org.uk) and has been awarded NIHR funding for the clinical application of next generation sequencing techniques (NGST). This funding will be used to deliver ~5,000 exomes per year for the next 3-5 years and applications to use this facility are invited from NIHR BRC researchers.
Read more
Professor Jonathan Weber has been appointed to the new combined role across Imperial College Healthcare NHS Trust and Imperial College London
Read more
The NIHR Imperial BRC Imaging Theme has launched a call for pilot phase II projects that seek to accelerate clinical research through the use of enabling innovative imaging technologies.
Read more
On November 1 2012, the National Institute for Health Research (NIHR) Imperial BRC opened its doors to patients, healthcare professionals, A-Level Biology students and members of the local community of North West London to enable them to explore the variety and breadth of translational research being undertaken at the NIHR Imperial BRC.
Read more
Four NIHR Imperial BRC researchers have been commended as distinguished scientists by the Academy of Medical Sciences. Election to the Fellowship of the Academy is a mark of recognition to exceptional contributions made to the medical sciences in the form of novel original discovery or sustained contributions to scholarship.
Read more
April 1st, 2012 marks the beginning of the new NIHR Imperial BRC award. In August 2011, NIHR pledged £112M in funding to the NIHR Imperial Biomedical Research Centre to be used to facilitate the continued development of cutting-edge translational research and healthcare innovations within NIHR Imperial BRC over the course of the next five years.
Read more
On March 1st 2012, it was announced that the NIHR/Wellcome Trust Imperial Clinical Research Facility has been awarded £10.9M in funding from the NIHR, with effect from 1st September 2012. This NIHR investment is to support the translation of scientific advances into benefits for patients through purpose-built Clinical Research Facilities (CRFs).
Read more
NIHR Imperial BRC in partnership with Imperial Innovations sought applications from researchers within Imperial Academic Health Science Centre (AHSC) for funding of projects that support the early stages of drug/therapeutic discovery.
Read more
A key part of our vision is to translate biomedical research into practice. For much of this translation we work in partnership. Researchers are supported to translate their ideas and discoveries into new products or treatments through Imperial Innovations.
Read more
The BRC-supported study, led by Dr Claire Shovlin and published in Thorax used carefully timed blood samples in patients with the inherited blood vessel disease hereditary haemorrhagic telangiectasia (HHT) to identify a link between low iron levels and potentially lethal blood clots. These findings may lead to changes in routine venous thromboembolism (VTE) risk assessment and prevention strategies.
Read moreA sample of the many ways which we have delivered results.
